Increased Diabetes Prevalence Due to Medical Advances
|
By HospiMedica International staff writers Posted on 17 May 2016 |
A new study has concluded that the global increase in type 1 diabetes (T1D) mellitus is directly linked to reduced natural selection resulting from improved medical care.
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Researchers at the University of Adelaide (UA; Australia) and the University of Zurich (UZH; Switzerland) examined the prevalence of T1D in 118 countries and concurrent changes in life expectancy from 1950 to 2010 to test correlation of T1D to reduced natural selection, as measured by the Biological State Index. To do so, they first obtain country-specific estimates of T1D prevalence, life expectancy, obesity prevalence rate, urbanization rates, per capita sugars consumption, and per capita gross domestic product (GDP).
The data obtained were then matched to T1D prevalence in all the countries, which were also grouped to study associations in different geographical regions. After applying the Biological State Index to the data, they found that the rapid worldwide increase in T1D over the last few decades was directly linked with increases in human life expectancy, especially in Western countries, and therefore a reduction in natural selection. The study was published on March 2, 2106, in BMJ Open Diabetes Research & Care.
“The current prevailing paradigm on the increasing prevalence of T1D is that environmental pressures are now able to trigger genotypes. Currently, medical gene intervention in modern medicine at this stage cannot remove T1D genes, and eugenics can offer no direction due to ethics issue,” concluded study co-author Wen-Peng You, PhD, of UA. “Study of T1D epidemiology based on prevalence/incidence T1D data of all age groups has become imperative, as it may offer optimal solution to address, or at least slow down, T1D genetic load increases in different populations.”
“Natural selection is one of the major evolutionary forces that inform changes in our genes, across populations and over generations. This is the first major disease we have shown that is accumulating due to a relaxation of natural selection over time,” said study co-author Professor Maciej Henneberg, PhD, of UA and UZH. “It's unlikely this situation will ever be reversed, meaning that in order to overcome the problems associated with type 1 diabetes for our population, some form of gene therapy to repair the faulty genes may need to be considered.”
Natural selection, one of the basic mechanisms of evolution, is the differential survival and fertility of individuals due to differences in phenotype that reflect genetic differences. In modern society, natural selection still acts on all members of a population, selecting those that have an increased reproductive success due to survival and/or fertility. The Biological State Index takes into account potential loss of reproductive success by dying at an earlier age. The effect of natural selection on contemporary populations is declining due to modern medicine.
Related Links:
University of Adelaide
University of Zurich
Latest Critical Care News
- Octopus-Inspired Patch Improves Adhesion for Transdermal Drug Delivery
- Multimodal AI System Tracks Early Warning Signs of Mental Health Crisis
- Self-Folding Paper Sensor Conforms to Body Without Straps or Adhesives
- Patch-Based Therapy Promotes Myelin Repair in Multiple Sclerosis
- Rapid EHR Surveillance Helps Protect High-Risk Patients During Heat Waves
- Remote Cardiac Device Monitoring System Shows Safety and Cost Benefits
- Ambulatory ECG Monitor Improves Arrhythmia Detection in Syncope
- New Prediction Tool Supports Confident Prescribing of Heart Failure Medicines
- Machine Learning Models Identify Higher-Risk Pregnancies Earlier in Care
- Wearable Hormone Monitor Enables At-Home Detection of Primary Aldosteronism
- Contactless AI Tool Detects Hypertension and Diabetes from Facial Video
- AI Tool Predicts Bladder Cancer from Electronic Health Records
- Personalized Neuromodulation System Receives FDA Clearance for PTSD Treatment
- New Multimodal Framework Targets Debilitating Form of Heart Failure
- Telehealth-Enabled Paramedic Program Supports Post-Discharge Heart Failure Care
- AI Software Update Boosts Image Quality and Workflow for Portable MRI System
Channels
Artificial Intelligence
view channel
AI Tools Show Potential to Detect Subtle Signs of Interval Breast Cancer
Interval breast cancers, diagnosed after a negative screening mammogram and before the next scheduled exam, remain an important measure of screening performance and are often more aggressive.... Read more
AI Framework Aims to Turn Medical Care from Reactive to Preventive
Health systems face rising burdens from aging populations, chronic disease, and workforce shortages. Medical artificial intelligence (AI) remains concentrated in diagnosis and decision support, leaving... Read moreSurgical Techniques
view channel
New Transvaginal Transducer Improves Imaging for Gynecology and Early Obstetrics
Transvaginal ultrasound is central to gynecology and early obstetrics, where clinicians must balance deep tissue penetration with high-resolution imaging. Switching probes to achieve this balance can interrupt... Read more
Mobile 3-in-1 Imaging System Advances Intraoperative Navigation
Globus Medical’s Excelsius3D intelligent 3-in-1 imaging system has received the CE Mark for commercial sale in the European Union and the United Kingdom. The addition of Excelsius3D expands the company’s... Read morePatient Care
view channel
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Weighted Blankets Reduce Anxiety in Hospitalized Adults
Anxiety is common among hospitalized adults and can impair recovery, disrupt sleep, and worsen mental health. Although clinicians often use nonpharmacologic strategies, bedside options that act quickly... Read moreMedical Imaging
view channel
AI Imaging Model Predicts Five-Year Breast Cancer Risk from 3D Mammograms
Breast cancer screening programs often struggle to stratify women by near-term risk, which can lead to missed cancers or unnecessary testing. Forecasting who will develop disease within five years is difficult... Read more
Spleen Imaging Signatures May Reveal Hidden Coronary Artery Disease Risk
Coronary artery disease (CAD) remains a leading cause of death despite major gains in managing traditional risk factors. Clinicians still struggle to quantify residual risk and the upstream biology that... Read more
FDA Clears Automated Musculoskeletal Ultrasound Platform for Arthritis Assessment
Musculoskeletal ultrasound is central to evaluating inflammatory arthritis and other joint conditions, but access is limited by workforce shortages and variability in image acquisition. In the United States,... Read more
Automated Platform Converts Super-Resolution Ultrasound into Vascular Biomarkers
Microvascular dysfunction, an early marker of glaucoma, cancer, and other systemic illnesses, often precedes overt clinical signs yet remains difficult to quantify deep in tissue. Super-resolution ultrasound... Read moreHealth IT
view channel
Registry-Driven Digital Outreach Boosts Use of Heart Failure Medicines
Heart failure affects more than 64 million people worldwide and is linked to high mortality, reduced quality of life, and heavy healthcare use. Although sodium-glucose cotransporter 2 inhibitors are proven... Read more
Nurse-Coordinated Care Model Improves Heart Failure Outcomes
Heart failure imposes heavy mortality, morbidity, and cost burdens worldwide, yet proven therapies remain underused in routine practice. This inadequate uptake contributes to preventable hospitalizations... Read morePoint of Care
view channel
Microneedle Patch Enables At-Home Monitoring of Acute Kidney Injury
Kidney disease is often silent in its early stages, making timely detection difficult outside clinical settings. Early biomarkers such as neutrophil gelatinase–associated lipocalin can require blood draws... Read more
Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices
Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. These limitations can slow diagnosis and restrict use... Read moreBusiness
view channel
Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more







